Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation. (2025)

Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation. (1)

Main content 1Search 2Footer 3

+AA-A High contrast

VHL Search Portal

Information and Knowledge for Health

  • português
  • español
  • english

Subject descriptor lookup Advanced Search

Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation.

Ratti, Francesca; Marino, Rebecca; Olthof, Pim B; Pratschke, Johann; Erdmann, Joris I; Neumann, Ulf P; Prasad, Raj; Jarnagin, William R; Schnitzbauer, Andreas A; Cescon, Matteo; Guglielmi, Alfredo; Lang, Hauke; Nadalin, Silvio; Topal, Baki; Maithel, Shishir K; Hoogwater, Frederik J H; Alikhanov, Ruslan; Troisi, Roberto; Sparrelid, Ernesto; Roberts, Keith J; Malagò, Massimo; Hagendoorn, Jeroen; Malik, Hassan Z; Olde Damink, Steven W M; Kazemier, Geert; Schadde, Erik; Charco, Ramon; de Reuver, Philip R; Groot Koerkamp, Bas; Aldrighetti, Luca.

Affiliation

  • Ratti F; Hepatobiliary Surgery Division, IRCCS Ospedale San Raffaele, Via Olgettina 60, Milano, Italy.
  • Marino R; Hepatobiliary Surgery Division, IRCCS Ospedale San Raffaele, Via Olgettina 60, Milano, Italy.
  • Olthof PB; Department of Surgery, Division of HPB and Transplant Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Pratschke J; Department of Surgery, Charité-Universitätsmedizin, Berlin, Germany.
  • Erdmann JI; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Neumann UP; Department of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, Aachen, Germany.
  • Prasad R; Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Jarnagin WR; Department of Hepatobiliary and Liver Transplant Surgery, Division of Surgery, St James's University Hospital, Leeds, United Kingdom.
  • Schnitzbauer AA; Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Cescon M; Department of General and Visceral Surgery, University Hospital, Goethe University, Frankfurt, Germany.
  • Guglielmi A; Department of General Surgery and Transplantation, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Lang H; Unit of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
  • Nadalin S; Department of General, Visceral and Transplant Surgery, University Hospital Mainz, Mainz, Germany.
  • Topal B; Department of General and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
  • Maithel SK; Department of Abdominal Surgery, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
  • Hoogwater FJH; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Alikhanov R; Department of Surgery, Section of Hepatobiliary Surgery & Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Troisi R; Department of Liver and Pancreatic Surgery, Moscow Clinical Scientific Center, Russia.
  • Sparrelid E; Department of Clinical Medicine and Surgery, Division of Hepato-Bilio-Pancreatic, Minimally Invasive and Robotic Surgery, Federico II University Hospital, Naples, Italy.
  • Roberts KJ; Department of Clinical Science, Intervention and Technology (CLINTEC), Division of Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Malagò M; Department of Surgery, University Hospital Birmingham, Birmingham, United Kingdom.
  • Hagendoorn J; Department of HPB- and Liver Transplantation Surgery, University College London, Royal Free Hospitals, London, United Kingdom.
  • Malik HZ; Department of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Olde Damink SWM; Department of Hepatobiliary Surgery, Aintree University Hospital, Liverpool University Hospitals, NHS Foundation Trust, Liverpool, United Kingdom.
  • Kazemier G; Department of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, Aachen, Germany.
  • Schadde E; Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Charco R; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
  • de Reuver PR; Department of Surgery, Cantonal Hospital Winterthur, Zurich, Switzerland.
  • Groot Koerkamp B; Department of HBP Surgery and Transplantation, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, Spain.
  • Aldrighetti L; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Hepatology ; 79(2): 341-354, 2024 02 01.

Article in En

| MEDLINE| ID: mdl-37530544

Subject(s)

Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis; Klatskin Tumor; Humans; Klatskin Tumor/surgery; Klatskin Tumor/complications; Medical Futility; Neoplasm Recurrence, Local/etiology; Cholangitis/complications; Hepatectomy/methods; Bile Duct Neoplasms/pathology; Cholangiocarcinoma/pathology; Retrospective Studies; Treatment Outcome

Print

XML

PubMed Links

PubMed Links

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangitis / Klatskin Tumor / Cholangiocarcinoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Hepatology Year: 2024 Type: Article Affiliation country: Italy

Print

XML

PubMed Links

PubMed Links

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangitis / Klatskin Tumor / Cholangiocarcinoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Hepatology Year: 2024 Type: Article Affiliation country: Italy

Consulta Detalhada

(instance:"regional") AND ( year_cluster:("2002") AND pais_afiliacao:("^iUnited States^eEstados"))(instance:"regional") AND ( year_cluster:("2002") AND pais_afiliacao:("^iUnited States^eEstados"))(instance:"regional") AND ( year_cluster:("2002") AND pais_afiliacao:("^iUnited States^eEstados"))(instance:"regional") AND ( year_cluster:("2002") AND pais_afiliacao:("^iUnited States^eEstados"))

Email
Export
Export format:
RSS

View RSS Add RSS to My VHL

Print

This page Selected references (0)

Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation. (2025)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Velia Krajcik

Last Updated:

Views: 6082

Rating: 4.3 / 5 (74 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Velia Krajcik

Birthday: 1996-07-27

Address: 520 Balistreri Mount, South Armand, OR 60528

Phone: +466880739437

Job: Future Retail Associate

Hobby: Polo, Scouting, Worldbuilding, Cosplaying, Photography, Rowing, Nordic skating

Introduction: My name is Velia Krajcik, I am a handsome, clean, lucky, gleaming, magnificent, proud, glorious person who loves writing and wants to share my knowledge and understanding with you.